Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the American Society of Hematology (ASH) Annual Meeting…
nice advantage from proteasome inhibitors such as bortezomib, as well as aggregate procedures toenhance proteasome inhibitor sensitivity, consistent with a take a look at led…
Researchers at Sylvester Comprehensive Most cancers Center on the College of Miami Miller College of medication have developed an animal version that permits them to…